REAL

The multitargeted receptor tyrosine kinase inhibitor sunitinib induces resistance of HER2 positive breast cancer cells to trastuzumab-mediated ADCC

Guti, Eliza and Regdon, Zsolt and Sturniolo, Isotta and Kiss, Alexandra and Kovács, Katalin and Demény, Máté and Szöőr, Árpád and Vereb, György and Szöllősi, János and Hegedűs, Csaba and Polgár, Zsuzsanna and Virág, László (2022) The multitargeted receptor tyrosine kinase inhibitor sunitinib induces resistance of HER2 positive breast cancer cells to trastuzumab-mediated ADCC. CANCER IMMUNOLOGY IMMUNOTHERAPY, 71 (9). pp. 2151-2168. ISSN 0340-7004 (print); 1432-0851 (online)

[img]
Preview
Text
s00262-022-03146-z.pdf
Available under License Creative Commons Attribution.

Download (10MB) | Preview
Item Type: Article
Subjects: R Medicine / orvostudomány > R1 Medicine (General) / orvostudomány általában > R850-854 Experimental medicine / kisérleti orvostudomány
Depositing User: Dr Árpád Szöőr
Date Deposited: 28 Sep 2022 09:35
Last Modified: 28 Sep 2022 09:35
URI: http://real.mtak.hu/id/eprint/150222

Actions (login required)

Edit Item Edit Item